Proton Pump Inhibitors in Pediatrics

Randomized, Open-Label, Multicentre Pharmacokinetic Studies of Two Dose Levels of Pantoprazole Granules in Infants and Children Aged 1 Month through

(2011) Brinda K. Tammara et al.   CLINICAL PHARMACOKINETICS

Pharmacokinetics and Tolerability of Rabeprazole in Children 1 to 11 Years Old With Gastroesophageal Reflux Disease

(2011) Peter N Zannikos et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Efficacy of Proton-Pump Inhibitors in Children With Gastroesophageal Reflux Disease: A Systematic Review

(2011) R. J. van der Pol et al.   PEDIATRICS

Update on the pharmacogenomics of proton pump inhibitors

(2011) Krisztina Hagymási et al.   PHARMACOGENOMICS

Effectiveness and Safety of Proton Pump Inhibitors in Infantile Gastroesophageal Reflux Disease

(2010) Tanner W Higginbotham   ANNALS OF PHARMACOTHERAPY

Pharmacodynamics and Safety of Pantoprazole in Neonates, Preterm Infants, and Infants Aged 1 Through 11 Months with a Clinical Diagnosis of Gastroesophageal Reflux Disease

(2010) Jaroslaw Kierkus et al.   DIGESTIVE DISEASES AND SCIENCES

Impact of the CYP2C19*17 Allele on the Pharmacokinetics of Omeprazole and Pantoprazole in Children: Evidence for a Differential Effect

(2010) G. L. Kearns et al.   DRUG METABOLISM AND DISPOSITION

Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD)

(2010) Robert M. Ward et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

A Multicenter, Randomized, Open-Label, Pharmacokinetics and Safety Study of Pantoprazole Tablets in Children and Adolescents Aged 6 Through 16 Years With Gastroesophageal Reflux Disease

(2010) Robert M. Ward et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Population Pharmacokinetic Modeling of Pantoprazole in Pediatric Patients From Birth to 16 Years

(2010) W. Knebel et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Efficacy and Safety of Pantoprazole Delayed-release Granules for Oral Suspension in a Placebo-controlled Treatment-withdrawal Study in Infants 1–11 Months Old With Symptomatic GERD

(2010) Harland Winter et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Gastric exocrine and endocrine secretion

(2009) Mitchell L Schubert   CURRENT OPINION IN GASTROENTEROLOGY

Impact of Intestinal CYP2C19 Genotypes on the Interaction between Tacrolimus and Omeprazole, but Not Lansoprazole, in Adult Living-Donor Liver Transplant Patients

(2009) K. Hosohata et al.   DRUG METABOLISM AND DISPOSITION

The missing linkage: what pharmacogenetic associations are left to find inCYP3A?

(2009) Minoli A Perera   Expert Opinion on Drug Metabolism & Toxicology

Pharmacodynamics and Systemic Exposure of Esomeprazole in Preterm Infants and Term Neonates with Gastroesophageal Reflux Disease

(2009) Taher Omari et al.   JOURNAL OF PEDIATRICS

Apnea, bradycardia and desaturation in preterm infants before and after feeding

(2009) C Slocum et al.   Journal of Perinatology

Age-Dependent Pharmacokinetics of Lansoprazole in Neonates and Infants

(2009) Weijiang Zhang et al.   PEDIATRIC DRUGS

Pharmacokinetics of the new proton pump inhibitor ilaprazole in Chinese healthy subjects in relation to CYP3A5 and CYP2C19 genotypes

(2008) Yalin Li et al.   CLINICA CHIMICA ACTA

Single-Dose Pharmacokinetics of Oral and Intravenous Pantoprazole in Children and Adolescents

(2008) Gregory L. Kearns et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The gastric HK-ATPase: structure, function, and inhibition

(2008) Jai Moo Shin et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Proton pump inhibitors in GORDAn overview of their pharmacology, efficacy and safety

(2008) Vincenzo Savarino et al.   PHARMACOLOGICAL RESEARCH